Anthracycline-based antibody drug conjugates having high in vivo tolerability

Markus Warmuth, Karin Foster, Ror1 as a therapeutic target for lung cancer ,(2007)

Sivasubramanian Baskar, Christoph Rader, Anti-human ror1 antibodies ,(2010)

Christian Rohlff, Jonathan Alexander Terrett, Alasdair Stamps, Anti-ror1 antibodies ,(2011)

Magdalena Dorywalska, Pavel Strop, Jody A. Melton-Witt, Adela Hasa-Moreno, Santiago E. Farias, Meritxell Galindo Casas, Kathy Delaria, Victor Lui, Kris Poulsen, Janette Sutton, Gary Bolton, Dahui Zhou, Ludivine Moine, Russell Dushin, Thomas-Toan Tran, Shu-Hui Liu, Mathias Rickert, Davide Foletti, David L. Shelton, Jaume Pons, Arvind Rajpal, Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0132282

Abdumalik A. Nishonov, Maurice O. Okello, Vasu Nair, Sanjaykumar Mishra, Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications ,(2010)

P Masiakowski, R.D. Carroll, A novel family of cell surface receptors with tyrosine kinase-like domain. Journal of Biological Chemistry. ,vol. 267, pp. 26181- 26190 ,(1992) , 10.1016/S0021-9258(18)35733-8

Thomas J. Kipps, Bing Cui, II George F. Widhopf, Therapeutic antibodies against ror-1 protein and methods for use of same ,(2012)

Janet A Warrington, Zhaomei Zhang, Thomas Stamey, Mamatha Mahadevappa, Gleason grade 4/5 prostate cancer genes ,(2002)

Matteo Salsa, Vittoria Lupi, Michele Caruso, Process for the preparation of morpholinyl anthracycline derivatives ,(2011)

John S. Kent, Cholesterol matrix delivery system for sustained release of macromolecules ,(1982)